FDA

The U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, promotes and protects the public health by, among other things, assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

www.fda.gov

FDA RSS Channel

Filters
List of articles in category FDA
Title Published Date
FDA approves novel treatment to target abnormality in sickle cell disease 25 November 2019
FDA approves first treatment for inherited rare disease 20 November 2019
FDA approves first targeted therapy to treat patients with painful complication of sickle cell disease 15 November 2019
FDA approves first therapy to treat patients with rare blood disorder 08 November 2019
Digital submission of adverse event reports for investigational new drug applications 29 October 2019
FDA approves new treatment for patients with migraine 11 October 2019
FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases 08 October 2019
FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic 03 October 2019
FDA announces voluntary recall of Sandoz ranitidine capsules following detection of an impurity 24 September 2019
FDA approves first oral GLP-1 treatment for type 2 diabetes 20 September 2019
FDA takes first action under new international collaboration with Australia and Canada 17 September 2019
FDA approves first treatment for patients with rare type of lung disease 09 September 2019
FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs 15 August 2019
FDA approves first therapy for rare joint tumor 02 August 2019
FDA approves first treatment for severe hypoglycemia that can be administered without an injection 25 July 2019
FDA approves first generics of Lyrica 22 July 2019
FDA approves new treatment for refractory multiple myeloma 03 July 2019
FDA approves first treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease of the central nervous system 27 June 2019
FDA seeks public feedback on new drug approval transparency efforts 26 June 2019
FDA approves first chemoimmunotherapy regimen for patients with relapsed or refractory diffuse large B-cell lymphoma 10 June 2019

Business & Industry

Research & Development

Conferences & Events

Regulatory Affairs